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Abstract
Background: The search for disease-modifying treatments for Parkinson’s disease advances, however necessary markers for
early detection of the disease are still lacking. There is compelling evidence that changes of postural stability occur at very
early clinical stages of Parkinson’s disease, making it tempting to speculate that changes in sway performance may even
occur at a prodromal stage, and may have the potential to serve as a prodromal marker for the disease.
Methodology/Principal Findings: Balance performance was tested in 20 individuals with an increased risk of Parkinson’s
disease, 12 Parkinson’s disease patients and 14 controls using a cross-sectional approach. All individuals were 50 years or
older. Investigated groups were similar with respect to age, gender, and height. An accelerometer at the centre of mass at
the lower spine quantified sway during quiet semitandem stance with eyes open and closed, as well as with and without
foam. With increasing task difficulty, individuals with an increased risk of Parkinson’s disease showed an increased variability
of trunk acceleration and a decrease of smoothness of sway, compared to both other groups. These differences reached
significance in the most challenging condition, i.e. the eyes closed with foam condition.
Conclusions/Significance: Individuals with an increased risk of Parkinson’s disease have subtle signs of a balance deficit
under most challenging conditions. This preliminary finding should motivate further studies on sway performance in
individuals with an increased risk of Parkinson’s disease, to evaluate the potential of this symptom to serve as a biological
marker for prodromal Parkinson’s disease.
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Introduction
For the progressive neurodegenerative disorder Parkinson’s
disease (PD), neuromodulatory or even neuroprotective therapy
could soon be available. The best effect of such a therapy will
undoubtedly be achieved when administered in the earliest as
possible disease phase. In order to accurately test neuroprotective
effects, potential drugs need to be challenged with markers of
disease progression. These markers, however, are not yet available
to a sufficient extent and quality [1].
Clinical PD is a disease with motor dysfunction as the leading
symptom. Postural instability is, as one of the four cardinal motor
features, part of this motor dysfunction. Until recently, it has been
considered to occur relatively late in the disease course. This is
reflected by the Hoehn&Yahr scale where ‘‘postural instability’’ is
represented only in the advanced stages 3 to 5 [2]. However, there
is accumulating evidence that changes of postural stability occur
even at early PD stages [3,4,5], and that postural instability
increases when PD deteriorates [6].
From a clinical point of view, there is no doubt about the
existence of prodromal motor symptoms. This is what the
clinicians experience from newly diagnosed PD patients who
report, e.g. about a history of reduced arm swing and reduced
ability to turn in difficult situations. In addition, people with highly
trained motor skills such as musicians and top athletes who do not
yet have PD, occasionally report about slowly progressive
problems in performing their movements in the usual velocity
and accuracy. As an example of such early changes, reduced
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soccer games up to eight years before PD was diagnosed [7]. A
recent study found altered gait parameters in LRRK2 G2019S
mutation carriers without a clinical diagnosis of PD [8]. This
mutation leads to a Parkinsonian syndrome with relatively high
probability. Based on their mean age at study inclusion (53 years)
and the knowledge about the penetrance of the LRRK2 gene
(28% at age 59 years [9]), approximately one out of four of their
study participants with a LRRK2 mutation will develop clinical
PD within the following six years. The finding that gait parameters
in individuals at increased risk for PD are altered in combination
with the probable association of gait and sway changes in PD [10]
make it intriguing to hypothesize that also sway parameters may
be changed in individuals at increased risk for PD.
Besides the occurrence of motor deficits the prodromal phase of
PD is associated with an increased probability of the occurrence of
non-motor symptoms such as depression, hyposmia, REM sleep
behaviour disorder (RBD), and of signs such as an enlarged
hyperechogenicity of the substantia nigra already indicating
neurodegenerative decline [11,12,13]. In more detail, depression
is associated with a 3-fold increased risk for future PD [14],
hyposmia with a 5-fold increased risk [15], and an enlarged
hyperechogenicity of the substantia nigra with an approximately
18-fold increased risk for future PD [16]. There is increasing
evidence that the combined occurrence of these factors could even
increase the risk for PD and that these individuals represent a high
risk group for PD (HR-PD) [17,18,19,20,21].
In this study we investigated sway of such HR-PD individuals to
test the hypothesis that the postural control system is affected
already at a prodromal stage of PD. As compensatory mechanisms
can make subtle changes of primary damaged networks invisible
[22,23] we used a demanding paradigm, and included parameters
of postural correction in the analysis.
Methods
Ethics
The study protocol was approved by the ethical committee of
the Medical Faculty of the University of Tuebingen, and all
individuals provided written informed consent.
Objective
The primary objective of the study was to test whether trunk
instability as a sign for subtle balance deficits even occur at
prodromal stages of PD. Secondary aim was to exploratively
analyze associations of trunk balance parameters with demo-
graphic and clinical parameters of the subgroups.
Individuals
A population of 20 individuals at high risk for future PD (HR-
PD individuals), 12 PD patients (all OFF-medication), and 14
controls were investigated in the frame of the PMPP study
(Progression markers in the suspected prediagnostic phase of Parkinson’s
disease). PD patients were diagnosed according to established
diagnostic criteria [24], and were only included if they had a
Hoehn&Yahr stage #2.5 (i.e. no clinical signs of postural
instability), were older than 50 years of age, had no deep brain
stimulation, and neither a history nor actual signs of a psychiatric
disease. Controls fulfilled the following criteria: they were more
than 50 years old, had a negative family history for PD [25] and
no signs for PD [24], a normal area of hyperechogenicity of the
substantia nigra [18], no history or actual signs of a psychiatric
disease, and no signs of hyposmia [26].
PD diagnosis was also excluded in HR-PD individuals [24]. In
addition, HR-PD individuals were defined as having the following
symptom/factor constellations: (1) the presence of an enlarged
area of hyperechogenicity of the substantia nigra (SN+ [18]) (all),
and the additional occurrence of (2a) one PD cardinal motor sign -
bradykinesia (N=12) or rigidity (N=7) as assessed with the
Unified Parkinson’s Disease Rating Scale (UPDRS) motor part
[17], irrespective of the co-occurrence of signs/risk factors as
mentioned in (2b) -, or (2b) two of the following signs/risk factors:
lifetime depression (N=7, according to the DSM-IV criteria) ,
hyposmia (N=6) [26], reduced arm swing (N=8), and positive
family history of PD (N=12) [25]. RBD was not used as a
particular inclusion/exclusion criterion. In the RBD question-
naire, three PD patients, one HR-PD individuals, and one control
scored .5 points which is suggestive of RBD.
Prior to sway measurement, all individuals underwent thorough
examination by neurologists experienced in the field of neurode-
generative diseases, semiquantitative motor evaluation (UPDRS
motor part), cognitive testing (Mini-Mental State Examination,
MMSE), evaluation of depressive symptoms (Beck’s Depression
Inventory, BDI), and quantification of pallaesthesia at the malleoli
using a 128-Hz tuning fork (WM, DB). None of the individuals
had a medical history of, or suffered from clinically detectable
polyneuropathy. For details see table 1.
Sway protocol
Participants were asked to stand upright in closed semitandem
stance, feet were allowed to be externally rotated for comfortable
standing, and arms flagged in self-chosen comfortable position.
Prior to sway measurements, participants were asked to perform
the most difficult task – eyes closed with foam (ECF) – to make
sure that under experimental conditions the tasks could be
adequately performed. All control and HR-PD individuals and
all but two PD patients were able to perform it. These two PD
patients were excluded from further analysis. Sway was assessed
with an inertial sensor with 100 Hz sample frequency (DynaPort
Hybrid, McRoberts, The Hague, the Netherlands), fixed with an
elastic belt at the level of the third and fourth lumbar spine
segment close to the centre of mass [27]. The sensing axes were
oriented along the anatomical anteroposterior (AP), mediolateral
(ML) and vertical directions. Four 30 seconds trials were
performed: i) eyes open condition (EO) with gaze straight ahead
at a white wall 2 meters in front, ii) eyes closed (EC), iii) eyes open
with foam (EOF; Airex balance pad, 5064166 cm), and iv) ECF.
The order of these conditions was randomly assigned for each
participant to omit a systemic bias due to learning effects.
Investigators were not specifically informed about the health status
of HR-PD and control individuals.
Data analysis and statistics
Pre-processing of acceleration signals has been previously
described in [5]. In summary, acceleration signals were trans-
formed to a horizontal-vertical coordinate system [28] and filtered
with a 3.5 Hz cut-off, zero-phase, low-pass Butterworth filter.
Then, the following parameters were evaluated from the
acceleration signals measured with the inertial sensor in the AP
and ML direction: Root mean square (RMS) of sway acceleration,
mean sway velocity (MV), frequency comprising 95% of the signal
(F95), and sway jerkiness (JERK) [5].
Statistical analysis was done with JMP 9.0, SAS. Data are
presented with mean and standard deviation. P-values were
assessed with ANOVA with post-hoc Student’s t test (continuous
data) or the Pearson Chi Square test, and were considered
significant at a 0.05 level. Associations of the two most relevant
Sway in High Risk Subjects for PD
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condition, with demographic/clinical parameters (independent
variables: cohorts, age, gender, weight, length, UPDRS motor
part, MMSE, BDI, SN status and pallaesthesia) were tested by use
of a linear and logistic regression model.
Results
HR-PD individuals were comparable to controls and PD
patients regarding age, gender, weight, height, MMSE score and
pallaesthesia. They did not differ significantly from controls
regarding UPDRS motor score and BDI score. As expected, both
HR-PD and control individuals had lower UPDRS motor scores
than PD patients. PD patients had a higher (worse) BDI score than
controls (table 1).
In the sway paradigm, with increasing task difficulty, HR-PD
individuals showed an increase of RMS values in both the AP and
the ML direction, compared to both control and PD individuals.
This difference reached significance in the most challenging
condition. Controls and PD patients did not differ significantly in
either task.
HR-PD individuals showed an increase of JERK values with
increasing difficulty of the sway task which also reached
significance in the most challenging condition, i.e. the ECF
condition (table 1, figure 1).
MV and F95% were comparable between groups under all
conditions tested (not shown).
Representative signals are shown in figure 2 to allow a visual
inspection of qualitative differences among trunk anteroposterior
acceleration across groups.
In a logarithmic model the influence of demographic and
clinical parameters on these two most relevant parameters was
tested. RMS and JERK were both significantly influenced by
cohort (as expected) and MMSE (R
2#46%; a logarithmic model
including the ECF sway parameters presented in table 1 and
figure 1 together with the MMSE lead to p-values#0.003, thus
MMSE values did not affect presented results) but not by gender,
weight, length, UPDRS III, BDI, SN status and pallaesthesia
score.
Discussion
To our knowledge, this is the first report on changes in sway
performance among healthy individuals with an increased risk of
PD. HR-PD individuals showed an increased variability of their
trunk acceleration pattern in particular under a difficult sway
condition, as compared to both PD patients and controls. These
results are coincident with what was recently found by Mirelman
and colleagues [8] in terms of gait variability in another high risk
cohort for Parkinsonism, i.e. in LRRK2 G2019S mutation
carriers. Comparable to what is discussed by these authors, our
findings may indicate subtle abnormalities of the central (here:
balance-related) networks as manifested during challenging
conditions, demonstrating decreased compensatory reserve. As
proposed by Bottaro and colleagues [29], the model best
explaining human body sway while quiet standing is a regular
(or periodic) interplay between a fall and a stabilization phase, with
an estimate of approximately 0.4 seconds per phase. Based on this
model, the increased variability of the trunk acceleration pattern in
HR-PD risk individuals may indicate a loss of capacity of the
central balance control system which is responsible for the
regularity (or periodicity) of the phases.
In addition, HR-PD individuals showed a more accentuated
increase of JERK, i.e. a decrease in smoothness of sway reflecting
Table 1. Demographic, clinical and sway parameters.
PD Individuals at high risk for PD Controls P-value
Individuals (females) 12 (5) 20 (7) 14 (7) 0.71
Age [ys] 61.5 (2.2) 61.9 (1.5) 63.9 (1.9) 0.53
Weight [kg] 79.3 (3.0) 78.2 (2.3) 72.6 (2.7) 0.18
Height [m] 1.74 (0.02) 1.73 (0.02) 1.72 (0.02) 0.80
BMI [kg/m
2] 26.2 (0.8) 25.9 (0.6) 24.6 (0.7) 0.24
Age at disease onset [ys] 57.9 (2.1)
Disease duration [ys] 4.3 (2.6)
Hoehn&Yahr [1–5] 2.0 (0.4)
UPDRS III [0–100] 26.5 (10.9) 3.3 (2.4)
# 1.1 (1.7)
# ,0.0001
MMSE [0–30] 29.2 (1.0) 29.2 (1.1) 29.7 (0.5) 0.23
SN hyperechogenicity (cm
2) 0.24 (0.03) 0.24 (0.03) 0.14 (0.05)
#{ ,0.0001
BDI [0–63] 10.2 (8.5) 5.9 (5.9) 3.5 (3.7)
# 0.02
Pallaesthesia [0–8] 7.3 (1.8) 7.1 (1.4) 7.9 (0.3) 0.17
ECF condition RMS ap (m/s
2) 0.19 (0.12) 0.35 (0.17)
# 0.17 (0.05)
{ 0.003
ECF condition JERK ap (m
2/s
5) 0.05 (0.04) 0.30 (0.37)
# 0.05 (0.04)
{ 0.01
ECF condition RMS ml (m/s
2) 0.18 (0.08) 0.28 (0.15) 0.17 (0.05) 0.03
ECF condition JERK ml (m
2/s
5) 0.13 (0.11) 0.56 (0.62)
# 0.09 (0.10)
{ 0.01
Data are presented with the mean and standard deviation. P-values were assessed by ANOVA with post-hoc Student’s t test, or with the Pearson test.
#p,0.017 compared to Parkinson’s disease (PD),
{p,0.017 compared to individuals at high risk for PD.
ap, anteroposterior; BDI, Beck’s Depression Inventory; BMI, Body Mass Index; ECF, eyes closed with foam; ml, mediolateral; MMSE, Mini Mental State Examination; RMS,
root mean square of sway; SN hyperechogenicity, mean area of hyperechogenicity of the substantia nigra; UPDRS III, motor part of the Unified Parkinson’s disease
Rating Scale.
doi:10.1371/journal.pone.0032240.t001
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difficulty which also reached significance in the most challenging
condition, i.e. semitandem stance on foam with closed eyes. The
intermittent stabilization scheme proposed by Bottaro and
colleagues [29] predicts that sway movements should be rather
smooth, because they are mainly driven by intrinsic dynamics (and
not by external input, or noise). In fact, an increase of JERK has
repeatedly been associated with disturbance of balance in
neurodegenerative disorders such as PD [5,30], and degenerative
cerebellar diseases [31]. It is intriguing to hypothesize that the
HR-PD individuals with the highest values may be those who most
probably will develop PD within the next years. This hypothesis
will be tested during the regularly performed follow-up visits.
Interestingly, HR-PD individuals were not only different from
controls regarding the abovementioned parameters but also from
PD patients (all without tremor, without clinical signs of postural
instability, a Hoehn&Yahr stage of #2.5 and a mean disease
duration of approximately 4 years), who showed values compa-
rable to the control cohort. This seems counterintuitive as PD
patients definitely suffer from a postural deficit as shown by clinical
and quantitative analyses [1,10,32,33]. However most of the
previous studies used different stance paradigms (i.e. parallel
Figure 1. Root mean square acceleration and JERK results. Root mean square acceleration and JERK in the anteroposterior direction, and
mediolateral direction, of 12 patients with Parkinson’s disease (PD), 20 individuals at increased risk for PD (HR-PD), and 14 controls when performing
increasingly difficult sway tasks. Note the different scaling in some of the graphs.
doi:10.1371/journal.pone.0032240.g001
Sway in High Risk Subjects for PD
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e32240stance and not semitandem), included patients with more
advanced disease course, and/or did not particularly focus on
the parameters assessed here (only recently accelerometer-based
trunk measures were introduced). One possible explanation for
this finding could be that in the absence of relevant rigidity and
bradykinesia - HR-PD individuals had UPDRS motor scores
comparable to controls, see table 1 - a decrease in trunk stability
has to be compensated by an increase of correction movements
whereas stiffening typically associated with the OFF state of PD
patients does not require such compensation. Another explanation
could be as follows: Balance disturbances are particularly
responsive to training effects [31,34,35,36]. PD patients - who
are aware of the occurrence of balance difficulties – may dispose of
a daily and intensely trained balance control system which has
developed some compensation strategies to postural instability.
Contrary, HR-PD individuals are not aware of the ongoing disease
process and thus do not specifically train their system, in particular
in quite a naı ¨ve task as semitandem stance they may disclose a
latent difficulty which may only occur under maximal challenge
and not in everyday situations.
Whatever the reasons are for the ‘‘improvement’’ of variability
of trunk acceleration and smoothness of sway in patients with PD
compared to the HR-PD group, it seems very probable that it is
not due to noise as we controlled for a number of potential
confounding parameters, namely gender, weight, length, UPDRS
III, MMSE, BDI, SN status and pallaesthesia score. Still, as the
sway parameters included here can only reflect parts of the highly
complex balance control system - which should function more
properly in a prodromal PD phase than in clinical PD, and
definitely deteriorates during the course of PD - changes of such
parameters in the course of, e.g. a neurodegenerative process may
not always follow linear curves.
Limitations
The risk of our HR-PD individuals for developing PD is not
exactly definable to date, but may be comparable to the risk of the
participants included in the abovementioned LRRK2 mutation
carriers study [8]. Similarly, it is most probable that only a
minority of our HR-PD individuals will develop PD within the
next years. Thus, the findings should be interpreted with caution
as we cannot exclude that deficits observed in the HR-PD
individuals might reflect, at least partly, an endophenotypic
marker and not an early biomarker of PD.
Conclusion
Balance dynamics under maximally challenging conditions - e.g.
with exclusion of proprioceptive components and use of difficult
stance conditions - might serve as new, sensitive biological markers
of prodromal PD.
Figure 2. Traces of representative individuals. Traces of the anteroposterior acceleration in the eyes open (EO), top, and eyes closed (EC),
bottom, foam trials for a representative subject for each group: Parkinson’s disease (PD) – dotted; increased risk for PD (HR-PD) – dashed; controls
(CTR) – solid line.
doi:10.1371/journal.pone.0032240.g002
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